Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
80Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.07M | $230.8K | $0.00 |
| 2024 | $656.4K | $150.4K | $0.00 |
| 2023 | $732.0K | $-387.5K | $-0.00 |
| 2022 | $3.47M | $1.10M | $0.00 |
| 2013 | $0.00 | $-4.36M | $-4.83 |
Social Signal Score
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $0.00
- Implied price
- $0.00
- Return from $0.00
- 15.8% a year
To earn 15.0% a year on these assumptions you'd need to buy at $0.00 — today's price is already 3.6% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 0 | 2 | 4 | 6 | 8 |
|---|---|---|---|---|---|
| -2.0% | — | -8.5% | 5.1% | 14.0% | 20.8% |
| 3.0% | — | -3.8% | 10.5% | 19.8% | 26.9% |
| 8.0% | — | 0.9% | 15.8% | 25.6% | 33.1% |
| 13.0% | — | 5.5% | 21.2% | 31.4% | 39.2% |
| 18.0% | — | 10.2% | 26.6% | 37.3% | 45.4% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (3)
- Newsaccessnewswire.com·2d ago·Negative
MDCE Highlights StrainScan Pro for Multi-Billion-Dollar Cannabis Dispensary Sector with Enterprise iPad Air Solution (OTC Pink:MDCE) Proprietary AI Vision Platform Delivers Rapid Strain Identification and Quality Verification Tools for Licensed Multi-Location Dispensary Operators MESA, AZ / ACCESS Newswire / August 13, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today highlighted the application of its already-launched StrainScan Pro platform for licensed cannabis dispensary operators,…
View source ↗ - Newsaccessnewswire.com·3d ago·Negative
MDCE Positions StrainScan Pro for $4 Trillion Global Foodservice Market via Enterprise iPad Air Installations (OTC Pink:MDCE) AI-Powered Visual Intelligence Platform Designed for Quality Monitoring in Restaurants, Commercial Kitchens, and High-Volume Food Operations MESA, AZ / ACCESS Newswire / August 12, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced the positioning of its StrainScan Pro platform for the global foodservice sector, targeting restaurants, commercial kitchen
View source ↗ - Newsaccessnewswire.com·5d ago·Negative
MDCE Targets $5 Trillion Global Agriculture Market with StrainScan Pro Enterprise Deployment on iPad Air (OTC Pink:MDCE) Proprietary AI Vision Platform Designed for On-Device Quality Grading and Produce Inspection Across Farming and Post-Harvest Operations MESA, AZ / ACCESS Newswire / August 10, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today highlighted the expansion of its StrainScan Pro platform into agricultural quality control, positioning the proprietary AI vision software for
View source ↗